Prognostic factors | n | Median survival | Hazard Ratio | 95% Confidence Interval | P |
---|---|---|---|---|---|
Age, yrs | |||||
< 70 | 24 | 17.4 | |||
≥ 70 | 9 | 5.1 | 1.81 | 1.165–2.813 | 0.008 |
Gender | |||||
Male | 12 | 13.0 | |||
Female | 21 | 20.0 | 0.346 | 0.142–0.844 | 0.020 |
Smoking history | |||||
No smoking | 21 | 20.0 | |||
Smoking | 12 | 5.4 | 6.752 | 2.418–18.855 | < 0.001 |
Thoracoscopic findings | |||||
Pleural nodules | |||||
Yes | 24 | 15.6 | |||
No | 6 | 17.4 | 1.009 | 0.399–2.554 | 0.985 |
Pleural hyperemia | |||||
Yes | 21 | 18.9 | |||
No | 9 | 15.3 | 0.573 | 0.223–1.468 | 0.246 |
Pleural adhesion | |||||
Yes | 6 | 5.4 | |||
No | 24 | 19.1 | 0.277 | 0.097–0.788 | 0.016 |
Pleural edema | |||||
Yes | 9 | 18.9 | |||
No | 21 | 17.1 | 0.908 | 0.404–2.038 | 0.814 |
Pleural plaques | |||||
Yes | 12 | 13.0 | |||
No | 18 | 19.1 | 0.387 | 0.170–0.879 | 0.023 |
Histological type | |||||
Epithelioid | 12 | 12.8 | |||
Non-epithelioid | 21 | 20.4 | 0.095 | 0.031–0.293 | < 0.001 |
Staging | |||||
I | 0 | ||||
II | 9 | 28.4 | |||
III | 15 | 17.1 | |||
IV | 9 | 3.0 | 21.042 | 6.156–71.923 | < 0.001 |
Therapeutic regimen | |||||
Chemotherapy | 21 | 20.0 | |||
Chemotherapy and radiotherapy | 3 | 15.3 | |||
No therapy | 9 | 3.0 | 0.087 | 0.021–0.359 | 0.001 |